Japan: Opening the Door to Global Clinical Trials
Author: Sara Gambrill
Volume discounts and licensing opportunities are available. For more information, call (866) 219-3440, option 1, or e-mail
sales@centerwatch.com.
In 2007, drug development in Japan exploded six-fold over 2006 and it continues to grow
at an astounding rate. CenterWatch’s latest special report,
Japan: Opening the Door to Global
Clinical Trials, takes a look at the country’s dramatic resurgence in the
Asia-Pacific region, the cultural differences in their clinical trials process, and how
Japan can be an integral part of your global clinical trial plans.
Key features include:
- Government initiatives driving growth
- Market intelligence
- Outsourcing strategies
- Drug development pipeline
- A list of CROs
- Charts and figures
Recommended for:
- Biotech and pharmaceutical companies seeking information on growth and
challenges in Japan’s clinical trials market
- Investment firms covering the life sciences industry in emerging markets
- CROs conducting business in Japan
Purchase a copy of this important resource and make Japan part of your global plans!